DK1119571T3 - Tricykliske Delta 3 piperidiner som alpha 2 antagonister. - Google Patents

Tricykliske Delta 3 piperidiner som alpha 2 antagonister.

Info

Publication number: DK1119571T3
Authority: DK; Denmark
Prior art keywords: piperidines; antagonists; alpha; tricyclic; delta
Prior art date: 1998-10-06

Application number

DK99950627T

Other languages

English (en)

Inventor

Ludo Edmond J Kennis

Den Keybus F M A Janssen P Van

Josephus C Mertens

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-06

Filing date

1999-10-01

Publication date

2003-05-26

1999-10-01 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2003-05-26 Application granted granted Critical

2003-05-26 Publication of DK1119571T3 publication Critical patent/DK1119571T3/da

Links

239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 title 1
150000003053 piperidines Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Hematology (AREA)
Psychiatry (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Hydrogenated Pyridines (AREA)

DK99950627T 1998-10-06 1999-10-01 Tricykliske Delta 3 piperidiner som alpha 2 antagonister. DK1119571T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP98203370		1998-10-06
PCT/EP1999/007419 WO2000020421A2 (en)	1998-10-06	1999-10-01	TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS

Publications (1)

Publication Number	Publication Date
DK1119571T3 true DK1119571T3 (da)	2003-05-26

Family

ID=8234191

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99950627T DK1119571T3 (da)	1998-10-06	1999-10-01	Tricykliske Delta 3 piperidiner som alpha 2 antagonister.

Country Status (30)

Country	Link
US (1)	US6495555B1 (da)
EP (1)	EP1119571B1 (da)
JP (1)	JP4590101B2 (da)
KR (1)	KR20010071843A (da)
CN (1)	CN1131230C (da)
AR (1)	AR024216A1 (da)
AT (1)	ATE232869T1 (da)
AU (1)	AU760502B2 (da)
BG (1)	BG64872B1 (da)
BR (1)	BR9913507A (da)
CA (1)	CA2345622C (da)
CZ (1)	CZ20011104A3 (da)
DE (1)	DE69905478T2 (da)
DK (1)	DK1119571T3 (da)
EE (1)	EE04770B1 (da)
ES (1)	ES2193751T3 (da)
HU (1)	HUP0104002A3 (da)
ID (1)	ID28032A (da)
IL (1)	IL142443A0 (da)
NO (1)	NO20011270D0 (da)
NZ (1)	NZ510115A (da)
PL (1)	PL347894A1 (da)
PT (1)	PT1119571E (da)
RU (1)	RU2230744C2 (da)
SI (1)	SI1119571T1 (da)
SK (1)	SK285585B6 (da)
TR (1)	TR200100952T2 (da)
TW (1)	TWI248441B (da)
UA (1)	UA69420C2 (da)
WO (1)	WO2000020421A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4590102B2 (ja) *	1998-10-06	2010-12-01	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	医薬としての三環性δ３−ピペリジン類
AU2003219199A1 (en) *	2002-04-03	2003-10-13	Orion Corporation	Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
AU2005233456A1 (en)	2004-04-12	2005-10-27	Taisho Pharmaceutical Co., Ltd.	Cyclic amine compound
US20060035939A1 (en) *	2004-07-14	2006-02-16	Japan Tobacco Inc.	3-Aminobenzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity
WO2006006741A1 (ja) *	2004-07-15	2006-01-19	Japan Tobacco Inc.	縮合ベンズアミド化合物及びバニロイド受容体１型(ｖｒ１)活性阻害剤
US7906508B2 (en) *	2005-12-28	2011-03-15	Japan Tobacco Inc.	3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity
NZ596137A (en)	2009-05-14	2013-08-30	Janssen Pharmaceutica Nv	Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
WO2015091414A2 (de)	2013-12-19	2015-06-25	Bayer Pharma Aktiengesellschaft	Substituierte piperidinyl-tetrahydrochinoline
EP3083610A1 (de)	2013-12-19	2016-10-26	Bayer Pharma Aktiengesellschaft	Substituierte bipiperidinyl-derivate als adrenrezeptor alpha 2c antagonisten
KR20160098424A (ko) *	2013-12-19	2016-08-18	바이엘 파마 악티엔게젤샤프트	치환된 피페리디닐-테트라히드로퀴놀린
CN114276359B (zh) *	2022-01-05	2023-05-05	浙江大学	一种1,2,3,4-四氢苯并[4,5]呋喃[2,3-c]吡啶衍生物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU926914A1 (ru) *	1980-05-26	1992-04-23	Научно-исследовательский институт фармакологии АМН СССР	Производные 1,2,3,4-тетрагидробензофуро[3,2-с]-пиридина или хлоргидрат, обладающие р дом свойств анальгетиков и антагонистов морфина
DE3522959A1 (de) *	1985-06-27	1987-01-08	Merck Patent Gmbh	Indolderivate
US4673680A (en) *	1985-09-18	1987-06-16	Pendleton Robert G	α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
EP0339959A3 (en) *	1988-04-27	1991-03-20	Glaxo Group Limited	Lactam derivatives
US4971974A (en)	1988-06-16	1990-11-20	Neurex Corporation	Benzothiophenes as appetite suppressants
US5100891A (en) *	1991-01-18	1992-03-31	Hoechst-Roussel Pharmaceuticals Inc.	Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
ES2168682T3 (es) *	1996-12-06	2002-06-16	Abbott Lab	Compuestos alfa-1 adrenergicos a base de benzopiranopirrol y de benzopiranopiridina.
ES2238778T3 (es)	1997-12-25	2005-09-01	Meiji Seika Kaisha, Ltd.	Derivados de tetrahidrobenzoindol.
JP4590102B2 (ja) *	1998-10-06	2010-12-01	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	医薬としての三環性δ３−ピペリジン類

1999
- 1999-01-10 UA UA2001031999A patent/UA69420C2/uk unknown
- 1999-10-01 CZ CZ20011104A patent/CZ20011104A3/cs unknown
- 1999-10-01 CN CN99811682A patent/CN1131230C/zh not_active Expired - Fee Related
- 1999-10-01 SI SI9930264T patent/SI1119571T1/xx unknown
- 1999-10-01 CA CA002345622A patent/CA2345622C/en not_active Expired - Fee Related
- 1999-10-01 IL IL14244399A patent/IL142443A0/xx not_active IP Right Cessation
- 1999-10-01 RU RU2001111812/04A patent/RU2230744C2/ru not_active IP Right Cessation
- 1999-10-01 AU AU63341/99A patent/AU760502B2/en not_active Ceased
- 1999-10-01 ID IDW20010780A patent/ID28032A/id unknown
- 1999-10-01 NZ NZ510115A patent/NZ510115A/xx unknown
- 1999-10-01 PT PT99950627T patent/PT1119571E/pt unknown
- 1999-10-01 EE EEP200100209A patent/EE04770B1/xx not_active IP Right Cessation
- 1999-10-01 DE DE69905478T patent/DE69905478T2/de not_active Expired - Lifetime
- 1999-10-01 TR TR2001/00952T patent/TR200100952T2/xx unknown
- 1999-10-01 AT AT99950627T patent/ATE232869T1/de not_active IP Right Cessation
- 1999-10-01 DK DK99950627T patent/DK1119571T3/da active
- 1999-10-01 US US09/806,547 patent/US6495555B1/en not_active Expired - Lifetime
- 1999-10-01 PL PL99347894A patent/PL347894A1/xx not_active Application Discontinuation
- 1999-10-01 BR BR9913507-8A patent/BR9913507A/pt not_active IP Right Cessation
- 1999-10-01 EP EP99950627A patent/EP1119571B1/en not_active Expired - Lifetime
- 1999-10-01 HU HU0104002A patent/HUP0104002A3/hu unknown
- 1999-10-01 TW TW088116898A patent/TWI248441B/zh not_active IP Right Cessation
- 1999-10-01 SK SK432-2001A patent/SK285585B6/sk unknown
- 1999-10-01 ES ES99950627T patent/ES2193751T3/es not_active Expired - Lifetime
- 1999-10-01 JP JP2000574533A patent/JP4590101B2/ja not_active Expired - Fee Related
- 1999-10-01 KR KR1020017000442A patent/KR20010071843A/ko not_active Ceased
- 1999-10-01 WO PCT/EP1999/007419 patent/WO2000020421A2/en not_active Ceased
- 1999-10-05 AR ARP990105038A patent/AR024216A1/es not_active Application Discontinuation
2001
- 2001-03-12 BG BG105332A patent/BG64872B1/bg unknown
- 2001-03-13 NO NO20011270A patent/NO20011270D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ES2193751T3 (es)	2003-11-01
EE04770B1 (et)	2007-02-15
JP2002526545A (ja)	2002-08-20
EE200100209A (et)	2002-06-17
NO20011270L (no)	2001-03-13
AU760502B2 (en)	2003-05-15
CZ20011104A3 (cs)	2001-12-12
BG105332A (en)	2001-11-30
SK285585B6 (sk)	2007-04-05
AR024216A1 (es)	2002-09-25
NO20011270D0 (no)	2001-03-13
WO2000020421A2 (en)	2000-04-13
CA2345622C (en)	2007-12-04
PL347894A1 (en)	2002-04-22
RU2230744C2 (ru)	2004-06-20
CN1332744A (zh)	2002-01-23
DE69905478T2 (de)	2004-03-18
DE69905478D1 (de)	2003-03-27
PT1119571E (pt)	2003-06-30
TR200100952T2 (tr)	2001-10-22
SI1119571T1 (en)	2003-08-31
TWI248441B (en)	2006-02-01
KR20010071843A (ko)	2001-07-31
CN1131230C (zh)	2003-12-17
ID28032A (id)	2001-05-03
EP1119571A2 (en)	2001-08-01
NZ510115A (en)	2002-11-26
ATE232869T1 (de)	2003-03-15
IL142443A0 (en)	2002-03-10
HUP0104002A2 (hu)	2002-03-28
BG64872B1 (bg)	2006-07-31
AU6334199A (en)	2000-04-26
CA2345622A1 (en)	2000-04-13
US6495555B1 (en)	2002-12-17
HK1038010A1 (en)	2002-03-01
EP1119571B1 (en)	2003-02-19
WO2000020421A3 (en)	2000-08-03
HUP0104002A3 (en)	2003-12-29
JP4590101B2 (ja)	2010-12-01
BR9913507A (pt)	2001-06-05
UA69420C2 (uk)	2004-09-15
SK4322001A3 (en)	2002-01-07

Publication	Publication Date	Title
ID29241A (id)	2001-08-16	Turunan-turunan kinolin teranelasi-1,2
TR199800375A3 (tr)	1999-05-21	Selant kompozisyonlari.
ATE435861T1 (de)	2009-07-15	12,13-cyclopropan-epothilonderivate
NO20023485L (no)	2002-09-03	1,3-disubstituerte pyrrolidiner som alfa-2- adrenoceptorantagonister
MXPA03006991A (es)	2003-11-18	Derivados de piperidina como antagonistas de neurocinina 1.
NO20001609L (no)	2000-03-28	Aminoterminert trunkerte RANTES som kjemokinantagonister
DK0871623T3 (da)	2003-03-31	3-Azetinidylalkylpiperidiner eller -pyrrolidiner som tachykininantagonister
ID28874A (id)	2001-07-12	Inhibitor fosfodiesterase 4 turunan ftalazina.
NO20010873D0 (no)	2001-02-21	Mikropartikkel-blanding
DK0964863T3 (da)	2003-08-04	Oxazolidinoner som 5-HT2A-antagonister
ID26909A (id)	2001-02-15	Turunan-turunan 1,3,4-oksadiazolon
NO20011270L (no)	2001-03-13	Tricykliske <delta>3-piperidiner som <alfa>2-antagonister
DK1075471T3 (da)	2005-01-17	Idolylderivater som serotonerge midler
DK1149106T3 (da)	2003-07-14	4,5-azolo-oxindoler
NO992066D0 (no)	1999-04-29	Piperazinoderivater som neurokininantagonister
NO20000434D0 (no)	2000-01-27	Lyksofuranosyl benzimidazoler som antivirale midler
ITTO970975A0 (it)	1997-11-07	Composizioni organiche.
NO20011402D0 (no)	2001-03-20	Tricykliske <delta>3-piperidiner som farmasøytiske midler
NO20002575D0 (no)	2000-05-19	Substituerte oksimer som neurokininantagonister
TR199700041A2 (tr)	1997-08-21	Deterjan bilesimi.
ID26368A (id)	2000-12-14	Turunan-turunan 2 deoksi higromisin
DK0882044T3 (da)	2002-09-02	1,4-dihydropyridinforbindelser som bradykinin-antagonister
NO20011038D0 (no)	2001-02-28	Substituerte dihydrobenzopyraner nyttige som antiarytmiske midler
NO20005756D0 (no)	2000-11-14	Karboksy-substituerte karboksamidderivater som tachykininantagonister
NO20011309L (no)	2001-03-15	Benzotieno [3,2-c]pyridiner som<alfa>2-antagonister